The days after a serious injury may offer doctors an opportunity to protect a patient’s mental health as well as repair physical damage.
A small University of Florida study suggests that the antidepressant fluoxetine may reduce post-traumatic stress symptoms when given during recovery from major injuries.
Fluoxetine is widely known by the brand name Prozac. In the study, patients who received the medicine after traumatic injuries showed a greater decline in PTSD-related symptoms over the following year than patients given calcium.
Trauma medicine traditionally focuses first on survival and physical recovery. Doctors may need to stop bleeding, repair broken bones, prevent infection and help patients regain movement, but emotional effects can continue long after the visible injuries have healed.
Researchers say roughly half of people with traumatic injuries experience some decline in mental health afterward. Not everyone develops PTSD, but fear, depression, sleep problems, pain and repeated memories of the event can make recovery much harder.
PTSD can develop after a person experiences or witnesses an event involving serious injury, death or the threat of harm. The condition can affect relationships, work, sleep and daily life, and symptoms may continue for months or years.
University of Florida orthopedic surgeon Dr. Jennifer Hagen and her colleagues wondered whether waiting for serious symptoms to appear was the only option. They wanted to test whether medicine given earlier could reduce the development or severity of post-traumatic stress symptoms.
The team first tried a non-drug approach involving resilience training after injury. When that research produced little measurable improvement, the investigators worked with psychiatry specialists and decided to study fluoxetine.
Fluoxetine belongs to a commonly used group of antidepressants that affect serotonin signaling in the brain. Medicines in this group are often prescribed for depression and anxiety-related conditions, and antidepressants are also used in the treatment of PTSD.
The new study initially enrolled 68 people who had arrived at UF Health Shands Level I Trauma Center with major injuries. Patients had conditions such as serious limb fractures or broken pelvic bones.
Researchers randomly placed participants into two groups. One group took fluoxetine for nine months, while the comparison group received calcium, and both groups were monitored for three additional months.
By six months, only 35 participants remained in follow-up. At the final one-year assessment, 29 people contributed data, leaving the researchers with a much smaller group than the one that originally entered the study.
The patients taking fluoxetine reported a significant decline in post-traumatic stress symptoms over the year. By comparison, symptoms in the calcium group changed little overall.
The results suggest that fluoxetine might influence the mental health path that follows a traumatic injury rather than simply treating established symptoms later. The study also reported lower pain levels among people who took the antidepressant.
However, an important feature of the experiment limits how confidently the results can be interpreted. The trial was unblinded, so patients knew whether they were taking an antidepressant, and researchers also knew which treatment each patient had received.
Knowing that information can change expectations and possibly influence symptom reporting. This is particularly relevant when outcomes such as pain and post-traumatic stress are measured partly through what participants report about their own experiences.
The large loss of participants during follow-up creates another concern. People who stayed in the study may have differed in important ways from those who left, and the final sample of 29 people is too small to provide a definitive answer about preventive treatment.
The research team also highlighted the stigma surrounding mental health treatment. Some people may hesitate to enter studies involving antidepressants because they worry about being labeled as having a psychiatric condition, which can make this kind of trauma research difficult to conduct.
The study was published in the Journal of Orthopaedic Trauma. To test the idea more rigorously, the University of Florida researchers are now enrolling patients in a double-blind, placebo-controlled trial of fluoxetine after traumatic injury.
In that type of trial, neither the patients nor the researchers know who is receiving the real medicine during the study. This reduces the effect of expectations and is considered a stronger way to determine whether a treatment truly works.
For now, the findings should be considered an interesting early signal rather than proof that Prozac prevents PTSD. The small sample, high dropout rate and open knowledge of treatment assignment make replication essential before medical practice could change.
If the larger trial confirms the effect, the study could help change the way trauma teams think about recovery. Treating a broken bone may remain urgent, but protecting the mind from the lasting effects of the same traumatic event could eventually become another routine part of care.
If you care about mental health, please read studies that vegetarian diet may increase your depression risk, and Vitamin D could help reduce depression symptoms.
For more health information, please see recent studies about why pizza is a very addictive food, and MIND diet could improve cognitive health in older people.
Source: University of Florida.
